Physician

Philip Choi, MD

According to 2025 Medicare claims, Philip Choi, MD (NPI: 1588160857) practices medical toxicology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Queens, NY. This provider's primary affiliated billing organization is MEMORIAL SOLID TUMOR GROUP (NPI: 1699746172; TIN: 133278578) and primary practice location at 10065-6007.

Choi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 47 traditional Medicare patients, billed 113 HCPCS/CPT codes, and received $10,739 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 30 prescription claims across 17 beneficiaries totaling $49,191 in drug costs. Open Payments data shows 1 records totaling $75. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $632 to $49,191. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$5.4K$11K2024 Medicare payment: $10,739 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202447113$10,739

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$25K$49K2018 Drug cost: $632 (USD; Tot_Drug_Cst)2019 Drug cost: $9,743 (USD; Tot_Drug_Cst)2020 Drug cost: $2,373 (USD; Tot_Drug_Cst)2021 Drug cost: $1,959 (USD; Tot_Drug_Cst)2022 Drug cost: $2,736 (USD; Tot_Drug_Cst)2023 Drug cost: $426 (USD; Tot_Drug_Cst)2024 Drug cost: $49,191 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R12$632
20192254$9,743
20202035$2,373
20211520$1,959
2022N/R13$2,736
2023N/R17$426
20241730$49,191

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes2961$103
99238Hospital discharge day management, 30 minutes or less1313$71
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes1323$69

Top 5 Part D drugs in 2024

By total drug costs.

Part D summary data is connected for 2024, but public drug-level costs are not available, so a Top 5 by total drug costs cannot be shown.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$75Philips North America LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Philip Choi, MD?

Tedicare shows public-source Medicare data for Philip Choi, MD (NPI 1588160857), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Philip Choi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Philip Choi, MD?

Philip Choi, MD is linked to MEMORIAL SOLID TUMOR GROUP (billing NPI 1699746172) in the available physician profile data.

Does Philip Choi, MD have Open Payments data?

Philip Choi, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.